This announcement is a separate document:
富祥药业：长江证券承销保荐有限公司关于江西富祥药业股份有限公司2023年度内部控制自我评价报告的核查意见
Jiangxi Fushine Pharmaceutical: Inspection opinions of Changjiang Securities Underwriting and Sponsorship Co., Ltd. on the 2023 Internal Control Self-Assessment Report of Jiangxi Fuxiang Pharmaceutical Co., Ltd.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Hot News
Updated